View Product Understanding the Obesity Challenge in Canada What Is Retatrutide and How Does It Work The Triple Receptor Mechanism Explained Clinical Evidence: Phase 2 Trial Results Complete Weight Loss Timeline by Month Dosing Protocol and Administration Side Effects and How to Manage Them Who Benefits Most from Retatrutide Metabolic Benefits Beyond Weight Loss Retatrutide vs Other Weight Loss Medications Nutrition Strategies During Treatment Accessing Retatrutide in Canada Frequently Asked Questions Glossary of Terms References Understanding the Obesity Challenge in Canada Obesity has become one of the most pressing health concerns facing Canadians today
PMCID: PMC2935185 ) Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG (2013) Approach to the diagnosis and management of drug-induced immune thrombocytopenia
Dosing protocols differ substantially between the two medications, explains OrderlyMeds, which impacts both efficacy timelines and individual tolerance
Long-Term Safety Data Still Limited The longest published Retatrutide data extends to 68 weeks from the TRIUMPH-4 trial
Int Rev Neurobiol
| | | | | | | GLP-1 Receptor Agonists 2 GLP-1 Receptor Agonists (GLP-1 RAs) (Incretin Mimetic) GLP-1 (Glucagon-like Peptide-1) GLP-1 2 GLP-1 RAs : : Liraglutide (Victoza, Saxenda), Exenatide (Byetta) : Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide Extended-Release (Bydureon BCise) : Semaglutide (Rybelsus) GLP-1 RAs : GLP-1 Receptor Agonists GLP-1 : : : (Glucagon) (Gastric Emptying): : GLP-1 Receptor Agonists : 2 (Type 2 Diabetes Mellitus): ( Metformin) (Weight Management): GLP-1 RAs Liraglutide (Saxenda) Semaglutide (Wegovy) : (Major Adverse Cardiovascular Events - MACE) 2 GLP-1 Receptor Agonists : : (pre-filled pen) (Subcutaneous Injection) Liraglutide: (Daily) Semaglutide, Dulaglutide, Exenatide ER: (Weekly) : Semaglutide (Rybelsus) 30 ( 120
